ヨーロッパにおけるバイオテクノロジーの業界プロファイルは、市場規模（2019〜2024年の価値、および2029年までの予測）を含む、定性的および定量的な概要情報を提供します。また、主要財務指標を含む主要プレーヤーの説明と、市場における競争圧力の分析も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. AstraZeneca Plc
8.2. Novartis AG
8.3. Bayer AG
8.4. Novo Nordisk AS
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Europe biotechnology industry value: $ million, 2019-24
Table 2: Europe biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Europe biotechnology industry category segmentation: $ million, 2019-24
Table 4: Europe biotechnology industry geography segmentation: $ million, 2024
Table 5: Europe biotechnology industry value forecast: $ million, 2024-29
Table 6: AstraZeneca Plc: Key Facts
Table 7: AstraZeneca Plc: Annual Financial Ratios
Table 8: AstraZeneca Plc: Key Employees
Table 9: Novartis AG: Key Facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Bayer AG: Key Facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Bayer AG: Key Employees Continued
Table 17: Novo Nordisk AS: Key Facts
Table 18: Novo Nordisk AS: Annual Financial Ratios
Table 19: Novo Nordisk AS: Key Employees
Table 20: Europe Size of Population (Million), 2019-24
Table 21: Europe Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 22: Europe GDP (Current Prices, $ Billion), 2019-24
Table 23: Europe Inflation, 2019-24
Table 24: Europe Consumer Price Index (Absolute), 2019-24
Table 25: Europe Exchange Rate, 2019-24
List of Figures
Figure 1: Europe biotechnology industry value: $ million, 2019-24
Figure 2: Europe biotechnology industry category segmentation: $ million, 2019-24
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Europe biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2024
